Showing results (1-10 of 210) with videos related to
Sort By:
Pageof 21
Autoimmunity Reviews|July 13, 2004
Thrombogenicity of TNF alpha in rheumatoid arthritis defined through biological probes: TNF alpha blockersGianfranco Ferraccioli, Elisa GremeseGiornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 12, 2012
[Class IV-G and IV-S lupus nephritis, interstitial infiltrates and prognosis: state of the art and unmet medical needs]Gianfranco Ferraccioli, Elisa GremeseAutoimmunity Reviews|May 5, 2011
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular riskElisa Gremese, Gianfranco FerraccioliSwiss Medical Weekly|May 28, 2011
Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritisGianfranco Ferraccioli, Elisa GremeseInternal and Emergency Medicine|October 20, 2011
Pathogenetic, clinical and pharmaco-economic assessment in rheumatoid arthritis (RA)Gianfranco Ferraccioli, Elisa GremeseThe Journal of Rheumatology. Supplement|July 4, 2012
Should we consider tumor necrosis factor as the only target in spondyloarthritides?Gianfranco Ferraccioli, Elisa GremeseClinical Rheumatology|October 25, 2024
Are seronegative patients with rheumatoid arthritis and clinically suspect arthralgia properly represented in randomized clinical trials?Bernardo D'Onofrio, Carlo Selmi, Elisa GremeseRMD Open|April 3, 2023
Case report: crowned dens syndrome in a patient with seronegative rheumatoid arthritisGianfranco Ferraccioli, Romeo Zanardi, Elisa GremeseArthritis Research & Therapy|June 4, 2016
Could we use a lower dose of rituximab to treat rheumatoid arthritis in clinical practice: pros and cons?Gianfranco Ferraccioli, Barbara Tolusso, Elisa GremeseImmunotherapy|May 9, 2018
Abatacept in the treatment of psoriatic arthritis: biological and clinical profiles of the respondersGaetano Zizzo, Elisa Gremese, Gianfranco FerraccioliPageof 21